Prediction of response to pegylated interferon plus ribavirin by IL28B gene variation in patients with hepatitis C virus genotype 4

被引:0
|
作者
Shiha, Gamal [1 ,2 ]
Samir, Waleed [2 ]
Seif, Seham [1 ]
El-Etreby, Shahira A. [1 ]
Abdel-Khalek, Ehab [1 ]
机构
[1] Almansoura Univ Hosp, Dept Internal Med, Mansoura, Egypt
[2] ELRIAH, Mansoura, Egypt
关键词
D O I
暂无
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
1779
引用
收藏
页码:1023A / 1023A
页数:1
相关论文
共 50 条
  • [11] IL28B gene polymorphisms and viral kinetics in HIV/hepatitis C virus-coinfected patients treated with pegylated interferon and ribavirin
    Rallon, Norma I.
    Soriano, Vincent
    Naggie, Susanna
    Restrepo, Clara
    Goldstein, David
    Vispo, Eugenia
    McHutchison, John
    Benito, Jose M.
    AIDS, 2011, 25 (08) : 1025 - 1033
  • [12] ASSOCIATION OF IL28B GENE VARIATIONS WITH MATHEMATICAL MODELING OF VIRAL KINETICS IN CHRONIC HEPATITIS C PATIENTS WITH PEGYLATED INTERFERON PLUS RIBAVIRIN THERAPY
    Hsu, Ching-Sheng
    Hsu, Shih-Jer
    Liu, Chen-Hua
    Liu, Chun-Jen
    Kao, Jia-Horng
    HEPATOLOGY, 2010, 52 (04) : 759A - 759A
  • [13] The importance of IL28B polymorphism in response to pegylated interferon α and ribavirin in chronic hepatitis caused by HCV genotype 1b
    Mach, Tomasz
    Ciesla, Andrzej
    Sanak, Marek
    Glowacki, Mikolaj
    Warunek, Wioleta
    Owczarek, Danuta
    Ciecko-Michalska, Irena
    PRZEGLAD GASTROENTEROLOGICZNY, 2012, 7 (01): : 38 - 42
  • [14] Impact of IL28B gene polymorphisms rs8099917 and rs12980275 on response to pegylated interferon-α/ribavirin therapy in chronic hepatitis C genotype 4 patients
    Mahmoud A Khattab
    Hend M Abdelghany
    Maggie M Ramzy
    Rasha M Khairy
    The Journal of Biomedical Research, 2016, 30 (01) : 40 - 45
  • [15] Real world experience with pegylated interferon and ribavirin in hepatitis C genotype 1 population with favourable IL28B polymorphism
    Ekstrom, Victoria
    Kumar, Rajneesh
    Zhao, Yi
    Yee, Mei Ling
    Sung, Cynthia
    Toh, Dorothy
    Loh, Poh Yen
    Tan, Jessica
    Teo, Eng Kiong
    Chow, Wan Cheng
    GASTROENTEROLOGY REPORT, 2017, 5 (03): : 208 - 212
  • [16] Pegylated interferon plus ribavirin is suboptimal in IL28B CC carriers without rapid response
    Neukam, Karin
    Barreiro, Pablo
    Rivero-Juarez, Antonio
    Caruz, Antonio
    Mira, Jose A.
    Camacho, Angela
    Macias, Juan
    Rivero, Antonio
    Soriano, Vicente
    Pineda, Juan A.
    JOURNAL OF INFECTION, 2013, 67 (01) : 59 - 64
  • [17] Polymorphisms of interferon-λ4 and IL28B - effects on treatment response to interferon/ribavirin in patients with chronic hepatitis C
    Staettermayer, A. F.
    Strassl, R.
    Maieron, A.
    Rutter, K.
    Stauber, R.
    Strasser, M.
    Beinhardt, S.
    Datz, C.
    Scherzer, T. -M.
    Steindl-Munda, P.
    Gschwantler, M.
    Trauner, M.
    Hofer, H.
    Ferenci, P.
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2014, 39 (01) : 104 - 111
  • [18] IL28B AND ITPA GENE VARIANTS CORRELATE WITH TREATMENT EFFICACY IN PEGYLATED-INTERFERON PLUS RIBAVIRIN THERAPY FOR CHRONIC HEPATITIS C
    Matsuura, Kentaro
    Tanaka, Yasuhito
    Nishida, Nao
    Sugiyama, Masaya
    Watanabe, Tsunamasa
    Sugauchi, Fuminaka
    Kurosaki, Masayuki
    Izumi, Namiki
    Sakamoto, Naoya
    Enomoto, Nobuyuki
    Yatsuhashi, Hiroshi
    Nishiguchi, Shuhei
    Hino, Keisuke
    Kaneko, Shuichi
    Nojiri, Shunsuke
    Joh, Takashi
    Tokunaga, Katsushi
    Mizokami, Masashi
    HEPATOLOGY, 2011, 54 : 830A - 830A
  • [19] GENETIC POLYMORPHISM IN IL28B PREDICTS NULL VIROLOGICAL RESPONSE TO PEGYLATED-INTERFERON PLUS RIBAVIRIN THERAPY FOR CHRONIC HEPATITIS C
    Kurosaki, M.
    Tanaka, Y.
    Nishida, N.
    Sugiyama, M.
    Matsuura, K.
    Asahina, Y.
    Sugauchi, F.
    Sakamoto, N.
    Nakagawa, M.
    Watanabe, M.
    Sakai, A.
    Honda, M.
    Kaneko, S.
    Ito, K.
    Masaki, N.
    Tokunaga, K.
    Izumi, N.
    Mizokami, M.
    JOURNAL OF HEPATOLOGY, 2010, 52 : S451 - S452
  • [20] IL28B Genetic Variation and Treatment Response in Patients with Hepatitis C Virus Genotype 3 Infection
    Moghaddam, Amir
    Melum, Espen
    Reinton, Nils
    Ring-Larsen, Helmer
    Verbaan, Hans
    Bjoro, Kristian
    Dalgard, Olav
    HEPATOLOGY, 2011, 53 (03) : 746 - 754